Optimal mix of screening and contact tracing for endemic diseases

被引:24
作者
Armbruster, Benjamin [1 ]
Brandeau, Margaret L. [1 ]
机构
[1] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA
关键词
epidemic control; screening; contact tracing; optimal control; deterministic compartment model; costeffectiveness;
D O I
10.1016/j.mbs.2007.02.007
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Two common means of controlling infectious diseases are screening and contact tracing. Which should be used, and when? We consider the problem of determining the cheapest mix of screening and contact tracing necessary to achieve a desired endemic prevalence of a disease or to identify a specified number of cases. We perform a partial equilibrium analysis of small-scale interventions, assuming that prevalence is unaffected by the intervention; we develop a full equilibrium analysis where we compare the long-term cost of various combinations of screening and contact tracing needed to achieve a given equilibrium prevalence; and we solve the problem of minimizing the total costs of identifying and treating disease cases plus the cost of untreated disease cases. Our analysis provides several insights. First, contact tracing is only cost effective when prevalence is below a threshold value. This threshold depends on the relative cost per case found by screening versus contact tracing. Second, for a given contact tracing policy, the screening rate needed to achieve a given prevalence or identify a specified number of cases is a decreasing function of disease prevalence. As prevalence increases above the threshold (and contact tracing is discontinued), the screening rate jumps discontinuously to a higher level. Third, these qualitative results hold when we consider unchanged or changed prevalence, and short-term or long-term costs. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:386 / 402
页数:17
相关论文
共 31 条
[1]  
Bailey N. T. J., 1975, The mathematical theory of infectious diseases and its applications, V2nd
[2]  
*CDC, 2002, SEX TRANSM DIS TREAT
[3]  
*CDC, 2003, HIV AIDS SURV REP
[4]  
CDC, 1996, MMWR, V45
[5]  
*CDC, 2000, COMM TB CONTR ID PER, pCH10
[6]  
*CDC, 1993, PRIM SEC SYPH REP CA
[7]  
CLARKE J, 1998, CONTACT TRACING CHLA, P187
[8]  
COHEN DA, 2004, J ACQUIR IMMUNE DEFI, V37
[9]  
Cowan FM, 1996, GENITOURIN MED, V72, P247
[10]   Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations [J].
Dasgupta, K ;
Schwartzman, K ;
Marchand, R ;
Tennenbaum, TN ;
Brassard, P ;
Menzies, D .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (06) :2079-2086